Hopefully the R&D expenses are not a sign of real trouble in the continuing development of their flagship product. With all of their recent acquisitions, I guess that I am not surprised at some additional expense involved with integration of products and development (if that's what it was for). Hopefully this quarter will bear some fruit on the earnings side.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat